12:00 AM
 | 
Oct 28, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Entereg alvimopan regulatory update

Cubist said FDA approved an sNDA for Entereg alvimopan to accelerate upper and lower GI recovery following any surgery that includes a partial bowel...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >